Company reports Quarterly reportsAnnual reports PresentationsAnnouncementsAnnual General MeetingFinancial calendarCorporate governanceData of sharesConferences, roadshowsAnalystsContact Latest reports Richter Group Report - 3 months to March 2018421 kb 05/08/2018let lt sGedeon Richter Consolidated Financial Statements 20173302 kb 04/04/2018let lt sGedeon Richter Annual Report3267 kb 04/04/2018let lt s Latest announcements Pharmacovigilance Risk Assessment Committee (PRAC) published new recommendations subsequent to the Esmya® referral05/18/18Gedeon Richter Plc. announces today that subsequent to its meeting held on 14-17 May 2018 the Pharmacovigilance Risk Assessment Committee (PRAC) as a conclusion of its review procedure on drug induced liver injury potentially related to Esmya® published the following:Payment of dividends by Chemical Works of Gedeon Richter Plc05/11/18The Chemical Works of Gedeon Richter PLC (hereinafter: the "Company") would like to inform its shareholders that based on a resolution of the Annual General Meeting held on April 25, 2018, in the case of common shares: 68% of the nominal value, that is HUF 68 per share will be paid as dividends pursuant to paragraph 7.11.1 of the Company's Statutes, in a way that the Company will increase the payment, i.e. distribute the dividend after treasury shares among the shareholders entitled to dividend, in the proportion of their shares. The per share amount of dividend so increased will be established and published by the Company on June 5, 2018 on the website of the Budapest Stock Exchange and of the Company. Richter Group Report - 3 months to March 2018 05/08/18
Latest reports Richter Group Report - 3 months to March 2018421 kb 05/08/2018let lt sGedeon Richter Consolidated Financial Statements 20173302 kb 04/04/2018let lt sGedeon Richter Annual Report3267 kb 04/04/2018let lt s
Pharmacovigilance Risk Assessment Committee (PRAC) published new recommendations subsequent to the Esmya® referral05/18/18Gedeon Richter Plc. announces today that subsequent to its meeting held on 14-17 May 2018 the Pharmacovigilance Risk Assessment Committee (PRAC) as a conclusion of its review procedure on drug induced liver injury potentially related to Esmya® published the following:
Payment of dividends by Chemical Works of Gedeon Richter Plc05/11/18The Chemical Works of Gedeon Richter PLC (hereinafter: the "Company") would like to inform its shareholders that based on a resolution of the Annual General Meeting held on April 25, 2018, in the case of common shares: 68% of the nominal value, that is HUF 68 per share will be paid as dividends pursuant to paragraph 7.11.1 of the Company's Statutes, in a way that the Company will increase the payment, i.e. distribute the dividend after treasury shares among the shareholders entitled to dividend, in the proportion of their shares. The per share amount of dividend so increased will be established and published by the Company on June 5, 2018 on the website of the Budapest Stock Exchange and of the Company.
